Skip to main content
NewslettersWatchlist

Crescita Therapeutics Inc(CTX-T)
TSX

Today's Change
Real-Time Last Update

Crescita Therapeutics Inc

2805, Place Louis-R-Renaud
Laval QC H7V 0A3 CAN
P: 450-680-4722
https://www.crescitatherapeutics.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

    Key Executives

    NameTitle
    Serge VerreaultCEO/Director/President
    Jose DaRochaCFO

    More from The Globe

    Premarket: World shares climb on Fed cut bets, yen weakens
    NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
    The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada
    A trader works inside a booth on the floor of the New York Stock Exchange on May 1.
    The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings
    Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1.
    Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks
    Former President Donald Trump speaks to reporters as he leaves the courtroom for the day at Manhattan criminal court, in New York, U.S., April 30, 2024. Seth Wenig/Pool via REUTERS
    investor newsletter
    The key to successful investing. Plus, why Fairfax Financial is poised for an extraordinary run
    investor happy money
    The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive
    NEW YORK, NEW YORK - APRIL 29: Traders work on the floor of the New York Stock Exchange during morning trading on April 29, 2024 in New York City. Stocks opened high Monday morning amid a Federal Reserve rate decision and the monthly jobs report later this week. (Photo by Michael M. Santiago/Getty Images)
    Tuesday’s analyst upgrades and downgrades
    Samuel Drouin-Tardif, an electro-mechanic for Boralex, walks in the snow while looking at a wind turbine in Thetford Mines November 24, 2023.
    The close: Major indexes fall after wage data; cannabis shares surge on U.S. regulatory move
    The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.